The University of Washington’s Virology Lab has been working tirelessly since the COVID-19 pandemic began. It was one of the first labs to formulate a test for the presence of the virus and has processed thousands of these tests at its facilities. In fact, the university’s virology lab is currently processing its newest success in partnership with Abbott Labs’ antibody test for COVID-19.
The University has been running trials of Abbott Labs’ antibody blood tests, designed to find out who has natural or built-up immunity to COVID-19. The trials have proved to be incredibly successful.
Though showing immunity isn’t a cure, it is a major step to getting to that point. Knowing who is immune and who has had the virus before helps track the origins of the disease, knowing the components that can be used in a vaccine, and helps ensure the safety of bringing people back into the workforce. It is unclear how the antibodies of the novel coronavirus work or if you could get infected with the virus a second time, but Keith Jerome, the leader of the University of Washington’s virology program, assured that people with the antibodies will have more protection than those who do not. Receiving the virus a second time could result in more cold-like symptoms and not require the extreme hospitalization methods in place now.
The work being done in the study of antibodies through the University of Washington would not be possible without Abbott’s partnership. The antibody test produced by Abbott is not the first of its kind to be produced, but it is said to be the most reliable and the most sensitive in analyzation. In fact, Abbott’s test has correctly identified COVID-19 99.6% of the time against other viruses and has a 100% sensitivity to the coronavirus antibodies. Best of all, the test only takes about ten to fifteen minutes to retrieve the results.
“This starts to get us to the point that we can make a difference for the population of our area, get people back to work and give them back the lives that they were hoping for,” Jerome said.